These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26566160)

  • 1. Dogs as a Model for Cancer.
    Gardner HL; Fenger JM; London CA
    Annu Rev Anim Biosci; 2016; 4():199-222. PubMed ID: 26566160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving human cancer therapy through the evaluation of pet dogs.
    LeBlanc AK; Mazcko CN
    Nat Rev Cancer; 2020 Dec; 20(12):727-742. PubMed ID: 32934365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and comparative imaging.
    LeBlanc AK
    ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clinical trials in veterinary oncology.
    Burton J; Khanna C
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine tumors: a spontaneous animal model of human carcinogenesis.
    Pinho SS; Carvalho S; Cabral J; Reis CA; Gärtner F
    Transl Res; 2012 Mar; 159(3):165-72. PubMed ID: 22340765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
    Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
    ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology.
    Di Cerbo A; Palmieri B; De Vico G; Iannitti T
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1807-14. PubMed ID: 24816783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies.
    Jacob JA
    JAMA; 2016 Apr; 315(15):1550-2. PubMed ID: 27027696
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive modeling for cancer drug discovery using canine models.
    Lucroy MD; Suckow MA
    Expert Opin Drug Discov; 2020 Jun; 15(6):731-738. PubMed ID: 32176534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory.
    Paoloni M; Lana S; Thamm D; Mazcko C; Withrow S
    Vet J; 2010 Jul; 185(1):88-9. PubMed ID: 20621714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer researchers usher in dog days of medicine.
    Mack GS
    Nat Med; 2005 Oct; 11(10):1018. PubMed ID: 16211022
    [No Abstract]   [Full Text] [Related]  

  • 13. Studying Pets' Cancers May Yield Health Benefits For Humans.
    Jenks S
    J Natl Cancer Inst; 2015 Nov; 107(11):djv355. PubMed ID: 26538624
    [No Abstract]   [Full Text] [Related]  

  • 14. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
    Gordon I; Paoloni M; Mazcko C; Khanna C
    PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inductively coupled plasma mass-spectrometric determination of platinum in excretion products of client-owned pet dogs.
    Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH
    Vet Comp Oncol; 2015 Jun; 13(2):124-32. PubMed ID: 23714139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
    London CA; Hannah AL; Zadovoskaya R; Chien MB; Kollias-Baker C; Rosenberg M; Downing S; Post G; Boucher J; Shenoy N; Mendel DB; McMahon G; Cherrington JM
    Clin Cancer Res; 2003 Jul; 9(7):2755-68. PubMed ID: 12855656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first report of cases of pet dogs with naturally occurring cancer treated with the antitumor peptide CIGB-552.
    Vallespi MG; Rodriguez JC; Seoane LC; Alvarez P; Santana H; Garay H; Cabrera IA; Espinosa JT; Reyes O
    Res Vet Sci; 2017 Oct; 114():502-510. PubMed ID: 28987957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical study of dolastatin-10 in dogs with spontaneous neoplasia.
    Thamm DH; MacEwen EG; Phillips BS; Hershey AE; Burgess KM; Pettit GR; Vail DM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):251-5. PubMed ID: 11935218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fighting cancer in dogs. Morris Animal Foundation leads campaign to find cures.
    Rezendes A
    J Am Vet Med Assoc; 2007 May; 230(9):1287-8. PubMed ID: 17489135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.